INTRODUCTION: Perfusion computed tomography (PCT) allows to quantitatively assess haemodynamic characteristics of brain tissue. We investigated if different brain tumor types can be distinguished from each other using Patlak analysis of PCT data. METHODS: PCT data from 43 patients with brain tumours were analysed with a commercial implementation of the Patlak method. Four patients had low-grade glioma (WHO II), 31 patients had glioblastoma (WHO IV) and eight patients had intracerebral lymphoma. Tumour regions of interest (ROIs) were drawn in a morphological image and automatically transferred to maps of cerebral blood flow (CBF), cerebral blood volume (CBV) and permeability (K (Trans)). Mean values were calculated, group differences were tested using Wilcoxon and Mann Whitney U-tests. RESULTS: In comparison with normal parenchyma, low-grade gliomas showed no significant difference of perfusion parameters (p > 0.05) , whereas high-grade gliomas demonstrated significantly higher values (p < 0.0001 for K (Trans), p < 0.0001 for CBV and p = 0.0002 for CBF). Lymphomas displayed significantly increased mean K(Trans) values compared with unaffected cerebral parenchyma (p = 0.0078) but no elevation of CBV. High-grade gliomas show significant higher CBV values than lymphomas (p = 0.0078). DISCUSSION: PCT allows to reliably classify gliomas and lymphomas based on quantitative measurements of CBV and K (Trans).
INTRODUCTION: Perfusion computed tomography (PCT) allows to quantitatively assess haemodynamic characteristics of brain tissue. We investigated if different brain tumor types can be distinguished from each other using Patlak analysis of PCT data. METHODS: PCT data from 43 patients with brain tumours were analysed with a commercial implementation of the Patlak method. Four patients had low-grade glioma (WHO II), 31 patients had glioblastoma (WHO IV) and eight patients had intracerebral lymphoma. Tumour regions of interest (ROIs) were drawn in a morphological image and automatically transferred to maps of cerebral blood flow (CBF), cerebral blood volume (CBV) and permeability (K (Trans)). Mean values were calculated, group differences were tested using Wilcoxon and Mann Whitney U-tests. RESULTS: In comparison with normal parenchyma, low-grade gliomas showed no significant difference of perfusion parameters (p > 0.05) , whereas high-grade gliomas demonstrated significantly higher values (p < 0.0001 for K (Trans), p < 0.0001 for CBV and p = 0.0002 for CBF). Lymphomas displayed significantly increased mean K(Trans) values compared with unaffected cerebral parenchyma (p = 0.0078) but no elevation of CBV. High-grade gliomas show significant higher CBV values than lymphomas (p = 0.0078). DISCUSSION: PCT allows to reliably classify gliomas and lymphomas based on quantitative measurements of CBV and K (Trans).
Authors: Marius Hartmann; Sabine Heiland; Inga Harting; Volker M Tronnier; Clemens Sommer; Roman Ludwig; Klaus Sartor Journal: Neurosci Lett Date: 2003-02-27 Impact factor: 3.046
Authors: R J Jackson; G N Fuller; D Abi-Said; F F Lang; Z L Gokaslan; W M Shi; D M Wildrick; R Sawaya Journal: Neuro Oncol Date: 2001-07 Impact factor: 12.300
Authors: A Coulon; F Lafitte; K Hoang-Xuan; N Martin-Duverneuil; K Mokhtari; J Blustajn; J Chiras Journal: Eur Radiol Date: 2001-09-21 Impact factor: 5.315
Authors: Axel Gossmann; Thomas H Helbich; Nagato Kuriyama; S Ostrowitzki; Timothy P L Roberts; David M Shames; N van Bruggen; Michael F Wendland; Mark A Israel; Robert C Brasch Journal: J Magn Reson Imaging Date: 2002-03 Impact factor: 4.813
Authors: Meng Law; Stanley Yang; James S Babb; Edmond A Knopp; John G Golfinos; David Zagzag; Glyn Johnson Journal: AJNR Am J Neuroradiol Date: 2004-05 Impact factor: 3.825
Authors: Peter Schramm; Peter D Schellinger; Ernst Klotz; Kai Kallenberg; Jochen B Fiebach; Sonja Külkens; Sabine Heiland; Michael Knauth; Klaus Sartor Journal: Stroke Date: 2004-05-20 Impact factor: 7.914
Authors: A Stecco; F Fabbiano; P Amatuzzo; E Cignini; M Brambilla; L Masini; M Krengli; A Carriero Journal: Radiol Med Date: 2012-08-08 Impact factor: 3.469
Authors: S G Bowden; B J A Gill; Z K Englander; C I Horenstein; G Zanazzi; P D Chang; J Samanamud; A Lignelli; J N Bruce; P Canoll; J Grinband Journal: AJNR Am J Neuroradiol Date: 2018-01-25 Impact factor: 3.825
Authors: P Kickingereder; F Sahm; B Wiestler; M Roethke; S Heiland; H-P Schlemmer; W Wick; A von Deimling; M Bendszus; A Radbruch Journal: AJNR Am J Neuroradiol Date: 2014-04-10 Impact factor: 3.825
Authors: X Lin; M Lee; O Buck; K M Woo; Z Zhang; V Hatzoglou; A Omuro; J Arevalo-Perez; A A Thomas; J Huse; K Peck; A I Holodny; R J Young Journal: AJNR Am J Neuroradiol Date: 2016-12-08 Impact factor: 3.825
Authors: Francesca Granata; Rosa Morabito; Concetta Alafaci; Valeria Barresi; Francesco Tomasello; Sergio Vinci; Enricomaria Mormina; Alessandro Calamuneri; Giovanni Grasso; Francesco Maria Salpietro; Marcello Longo Journal: Neuroradiol J Date: 2015-06
Authors: Daniel S Chow; Craig I Horenstein; Peter Canoll; Angela Lignelli; Elizabeth M C Hillman; Christopher G Filippi; Jack Grinband Journal: AJR Am J Roentgenol Date: 2016-03-23 Impact factor: 3.959
Authors: K A Miles; T-Y Lee; V Goh; E Klotz; C Cuenod; S Bisdas; A M Groves; M P Hayball; R Alonzi; T Brunner Journal: Eur Radiol Date: 2012-02-26 Impact factor: 5.315